It is inconceivable to imagine our nation today without the gains of the Civil Rights Act. It is impossible to understand why the issue was so divisive then, since it is such an obvious right and moral proposition. Similarly, let us hope we will look back at the Affordable Care Act 20 years from now and wonder why it was such a contentious topic in 2014.
President Obama’s commencement address at West Point on Wednesday was clearly aimed at deflecting rising criticism of his administration’s foreign policy. In particular, the speech was designed to address complaints that U.S. foreign policy under Obama has lacked strategic coherence and signaled a U.S. retreat from the international arena. The administration promoted the address as a platform for the president to describe his “vision” for U.S. foreign policy during the remainder of his term. To the extent that the speech did present a vision, it was not a particularly new one.
As Israeli-Palestinian peace talks "stumble toward collapse," blogs fellow Joe Barnes, the U.S. "needs a thorough rethink" about its role in negotiations.
Joe Barnes, the institute's Bonner Means Baker Fellow, blogs on concern in Kyiv, Washington and European capitals — not too far-fetched, given Russia’s seizure of Crimea last month — that Moscow might invade Eastern Ukraine on the pretext of protecting Russian speakers.
Cancer drug shortages are almost uniquely associated with generic drugs (small profit margins) and rarely with patented drugs (large profit margins). They are common in the U.S., but uncommon in Europe and elsewhere, where generic drug prices are on average higher than in the U.S. This suggests the main cause of drug shortages is economic.
Baker Institute health policy experts Hagop M. Kantarjian and Vivian Ho explain why Texas, which holds the notorious record of the highest rate of uninsured citizens in the U.S., should follow many Republican-led states that are now reconsidering the Medicaid expansion program under Obamacare.
In a recent commentary, Baker Institute science and technology policy experts described two international court cases that aimed to define “research” — and that ultimately arrived at two different answers.
“What makes this interesting is that the courts’ definition of ‘research’ was based on politics — what the court wanted the end result to be,” said Kirstin Matthews, the institute’s fellow in science and technology policy. To reach a decision prohibiting human embryonic stem cell (hESC) patents, the EU court ruled that “research” occurs in a continuum. To reach a decision supporting federal funding of stem cell research, the U.S. court ruled that “research” involves a specific project.
